CCI approves proposed transaction involving Aster DM Healthcare, BCP Asia, Centella and Quality Care India Limited

News Competition Sanctions & Fines

Date: 15th Apr, 2025 Source: Competition Commission of India Country: India Original Source

Brief

"On 15/04/2025, the Competition Commission of India issued an update regarding CCI approves proposed transaction involving Aster DM Healthcare, BCP Asia, Centella and Quality Care India Limited. The proposed transaction includes the merger of Quality Care India Limited into Aster DM Healthcare, renaming it as Aster DM Quality Care Limited, with certain stakeholders retaining stakes in the merged entity."

This content is restricted.

Highlights content goes here...

This content is restricted.

Competition Commission of India

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

CCI approves proposed transaction involving Aster DM Healthcare, BCP Asia, Centella and Quality Care India Limited

Brief

Competition Commission of India

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

CCI approves proposed transaction involving Aster DM Healthcare, BCP Asia, Centella and Quality Care India Limited

Brief

Competition Commission of India

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.